Artwork

Content provided by Baptist Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Baptist Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Advances in Lung Cancer Treatment: Navigating Toward a Solution

25:20
 
Share
 

Manage episode 417183510 series 3393216
Content provided by Baptist Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Baptist Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Even with the success of reducing smoking, lung cancer remains the leading cause of cancer deaths worldwide for both men and women. In 2023, there were approximately 238,000 new lung cancers and 125,000 deaths in the United States alone. In recent decades, the evolution of robotic-assisted thoracic surgery has enhanced primary lung cancer treatment and postoperative outcomes. This, in combination with advances in immunotherapy and our understanding of cancer’s molecular biology, brings many tools to the battle against the leading cause of cancer deaths in the United States.

Join Dr. Mark Dylewski, chief of general thoracic surgery at Baptist Health, and Dr. Paul Kaywin, medical oncologist at Baptist Health Miami Cancer Institute, as they discuss advances in lung cancer treatment from a medical oncology and surgical perspective.

Mark Dylewski, M.D.

Director of General Thoracic Surgery and Robotic Thoracic Surgery

Chief of General Thoracic Surgery, Baptist Health

Chairman of Thoracic Surgical Oncology, Miami Cancer Institute

Paul Kaywin, M.D.

Medical Oncologist

Miami Cancer Institute

Baptist Health

  continue reading

20 episodes

Artwork
iconShare
 
Manage episode 417183510 series 3393216
Content provided by Baptist Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Baptist Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Even with the success of reducing smoking, lung cancer remains the leading cause of cancer deaths worldwide for both men and women. In 2023, there were approximately 238,000 new lung cancers and 125,000 deaths in the United States alone. In recent decades, the evolution of robotic-assisted thoracic surgery has enhanced primary lung cancer treatment and postoperative outcomes. This, in combination with advances in immunotherapy and our understanding of cancer’s molecular biology, brings many tools to the battle against the leading cause of cancer deaths in the United States.

Join Dr. Mark Dylewski, chief of general thoracic surgery at Baptist Health, and Dr. Paul Kaywin, medical oncologist at Baptist Health Miami Cancer Institute, as they discuss advances in lung cancer treatment from a medical oncology and surgical perspective.

Mark Dylewski, M.D.

Director of General Thoracic Surgery and Robotic Thoracic Surgery

Chief of General Thoracic Surgery, Baptist Health

Chairman of Thoracic Surgical Oncology, Miami Cancer Institute

Paul Kaywin, M.D.

Medical Oncologist

Miami Cancer Institute

Baptist Health

  continue reading

20 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide